Harbert Fund Advisors’s Fennec Pharmaceuticals FENC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-177,815	Closed	-$1.66M	–	4
2025 Q3	$1.66M	Sell	177,815 -109,799	-38%	-$950K	10.86%	5
2025 Q2	$2.39M	Sell	287,614 -179,255	-38%	-$1.23M	7.16%	6
2025 Q1	$2.84M	Hold	466,869	–	–	3.3%	8
2024 Q4	$2.95M	Hold	466,869	–	–	2.57%	19
2024 Q3	$2.33M	Hold	466,869	–	–	1.88%	26
2024 Q2	$2.85M	Hold	466,869	–	–	2.29%	14
2024 Q1	$5.19M	Hold	466,869	–	–	3.57%	8
2023 Q4	$5.24M	Hold	466,869	–	–	3.59%	8
2023 Q3	$3.51M	Hold	466,869	–	–	2.5%	18
2023 Q2	$4.12M	Hold	466,869	–	–	2.64%	18
2023 Q1	$3.88M	Buy	466,869 +149,920	+47%	+$1.39M	2.77%	13
2022 Q4	$3.04M	Buy	316,949 +127,199	+67%	+$1.13M	2.62%	15
2022 Q3	$1.54M	Hold	189,750	–	–	1.23%	35
2022 Q2	$1.06M	Hold	189,750	–	–	0.8%	35
2022 Q1	$1.06M	Hold	189,750	–	–	0.55%	34
2021 Q4	$835K	Buy	189,750 +15,000	+9%	+$112K	0.39%	38
2021 Q3	$1.65M	Buy	174,750 +53,899	+45%	+$404K	0.85%	29
2021 Q2	$881K	Buy	+120,851	New	+$807K	0.49%	27